Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-46.16	85.13	-158.10
Graham Fair Price	41.42	0.17	0.12
PEG	-27.41	-0.08	0.10
Price/Book	-21.01	0.95	1.20
Price/Cash Flow	65.49	-11.14	-32.28
Prices/Earnings	60.50	-7.62	-19.29
Price/Sales	-60.94	0.69	1.76
Price/FCF	65.49	-11.14	-32.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	17.54	0.07	0.06
Operating Margin	-80.61	< 0.005	-0.01
ROA	-100.00	-0.01	< 0.005
ROE	-0.02	-0.03	-100.00
ROIC	< 0.005	< 0.005	-60.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	-0.10	-96.92
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.17	1.39	705.93
EPS QOQ	-1.84	-1.00	45.59
FCF QOQ	0.74	-1.29	74.45
Revenue QOQ	-0.15	1.02	565.77
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.44	5.05	1039.07
Days Sales Outstanding (DSO)	134.22	66.87	-50.18
Inventory Turnover	202.92	17.81	-91.22
Debt/Capitalization	0.32	0.32	0.21
Quick Ratio	1.45	1.46	0.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.20	0.20	0.00
Cash	0.05	0.05	0.00
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	< 0.005	-0.02	-128.88
Revenue	0.14	0.27	102.21
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.59	1.59	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-24.82	16.32	-34.22
Naive Interpretation	Member

06 - Financial Health · Weak

Rating